Cullinan Therapeutics, Inc. (CGEM)
10.28
+0.09
(+0.88%)
USD |
NASDAQ |
Nov 13, 16:00
10.26
-0.02
(-0.19%)
After-Hours: 19:59
Cullinan Therapeutics Total Assets (Quarterly) : 322.56M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 322.56M |
| June 30, 2026 | 363.79M |
| March 31, 2026 | 402.98M |
| December 31, 2025 | 449.14M |
| September 30, 2025 | 484.13M |
| June 30, 2025 | 520.33M |
| March 31, 2025 | 579.68M |
| December 31, 2024 | 622.43M |
| September 30, 2024 | 653.25M |
| June 30, 2024 | 681.22M |
| March 31, 2024 | 449.43M |
| December 31, 2023 | 485.10M |
| September 30, 2023 | 494.71M |
| June 30, 2023 | 521.98M |
| Date | Value |
|---|---|
| March 31, 2023 | 514.99M |
| December 31, 2022 | 561.12M |
| September 30, 2022 | 617.24M |
| June 30, 2022 | 667.25M |
| March 31, 2022 | 437.46M |
| December 31, 2021 | 437.18M |
| September 30, 2021 | 453.40M |
| June 30, 2021 | 464.35M |
| March 31, 2021 | 479.67M |
| December 31, 2020 | 214.71M |
| September 30, 2020 | 97.32M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 100.46M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Climb Bio, Inc. | 236.56M |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.166B |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 41.28M |
| Shareholders Equity (Quarterly) | 281.28M |
| Debt to Equity Ratio | 0.0071 |
| Current Ratio | 7.430 |
| Net Debt Paydown Yield | -0.01% |